Published in
Elsevier, Gynecologic Oncology, 3(150), p. 432-437
DOI: 10.1016/j.ygyno.2018.07.014
Links
Tools
A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis
Journal article published in 2018 by
Shin Nishio 
,
Mototsugu Shimokawa,
Kazuto Tasaki,
Hiroki Nasu,
Teruyuki Yoshimitsu ,
Ken Matsukuma,
Atsumu Terada,
Naotake Tsuda,
Kouichiro Kawano,
Kimio Ushijima
,
Mototsugu Shimokawa,
Kazuto Tasaki,
Hiroki Nasu,
Teruyuki Yoshimitsu ,
Ken Matsukuma,
Atsumu Terada,
Naotake Tsuda,
Kouichiro Kawano,
Kimio Ushijima
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 